Concepedia

Origène Nyanguile

ON

19

Publications

1K

Citations

16

H-Index

1997

Active since

Affiliations

Janssen (Belgium)(Current)

HES-SO Valais-Wallis

Harvard University

École Polytechnique Fédérale de Lausanne

Research Institute for Genetic and Human Therapy

Origène Nyanguile is an author at Janssen (Belgium) specializing in medicine, molecular biology, and drug discovery.

ORCID

Top concepts

Publications per year

1997–2023

19

Publications

19

Induced α Helix in the VP16 Activation Domain upon Binding to a Human TAF

Motonari Uesugi, Origène Nyanguile, Hua Lu et al. · Science · 1997 · 289 citations

Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents

Ilia Fishbein, Ivan S. Alferiev, Origène Nyanguile et al. · Proceedings of the National Academy of Sciences · 2005 · 95 citations · Full text

Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors

Frederik Pauwels, Wendy Mostmans, Ludo Quirynen et al. · Journal of Virology · 2007 · 67 citations · Full text

Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase

Koen Vandyck, Maxwell D. Cummings, Origène Nyanguile et al. · Journal of Medicinal Chemistry · 2009 · 60 citations

A nonnatural transcriptional coactivator

Origène Nyanguile, Motonari Uesugi, David Austin et al. · Proceedings of the National Academy of Sciences · 1997 · 60 citations · Full text

Rows per page

1–5 of 19